BlinkLab (FRA:P41) Notes Receivable: €0.00 Mil (As of Dec. 2025)


FRA:P41 BlinkLab Ltd FRA:P41
16 GF Score
Price €0.33
! 2 Warning Signs
View Full Analysis

What is BlinkLab Notes Receivable?

BlinkLab FRA:P41 -2.40% 16 Notes Receivable is €0.00 Mil as of Dec. 2025. GuruFocus rates FRA:P41 with a GF Score™ of 16/100. The stock has 2 warning signs investors should review.

BlinkLab's Notes Receivable for the quarter that ended in Dec. 2025 was €0.00 Mil.

BlinkLab Notes Receivable Historical Data

* Premium members only.

The historical data trend for BlinkLab's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BlinkLab Notes Receivable Chart

BlinkLab Annual Data
Trend Jun23 Jun24 Jun25
Notes Receivable
0.00 0.00 0.00

BlinkLab Semi-Annual Data
Dec22 Jun23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
FRA:P41
16GF Score
BlinkLab Ltd FRA:P41
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BlinkLab Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of €0.00 Mil mean?
BlinkLab (FRA:P41) has a Notes Receivable of €0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on BlinkLab and its competitors.
Is BlinkLab's Notes Receivable too high?
BlinkLab's current Notes Receivable is €0.00 Mil. Overall, BlinkLab has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does BlinkLab's Notes Receivable compare to VEEV and BTSG?
BlinkLab's Notes Receivable of €0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on BlinkLab and its competitors. BlinkLab's current Notes Receivable is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BlinkLab stock overvalued right now?
BlinkLab (FRA:P41) has a current Notes Receivable of €0.00 Mil. The current Notes Receivable is €0.00 Mil. BlinkLab's overall GF Score™ is 16/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For BlinkLab (FRA:P41), the current Notes Receivable is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BlinkLab Business Description

Other Exchanges BB1:Australia
Address 216 Street Georges Tce, Level 4, Perth, WA, AUS, 6000
BlinkLab Ltd is a company that has the license to commercialize the Licensed IP and has developed a smartphone-based application with an e-platform that serves as a medical device to perform neurometric tests to aid in the diagnosis of ASD, ADHD, schizophrenia, and other neurodevelopmental conditions. The results from the BlinkLab Tests are recorded by smartphone and uploaded to BlinkLab's confidential and secure online platform where the data is analyzed.
16GF Score

Get the complete analysis for FRA:P41

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.33
Price